Dr. Jack West reviews treatment options for patients with an EGFR activating mutation and acquired resistance but no T790M mutation, focusing on a clinical trial with the novel hypoxia-induced pan-HER inhibitor TH4000.
Options for EGFR Mutation-Positive Patients with T790M Mutation-Negative Acquired Resistance [360p]
